Muscarinic agonists
US-11324738-B2 · May 10, 2022 · US
Rackham Mark David is listed as an inventor on 20 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Rackham Mark David |
| Total patents | 20 |
| First publication | Jan 19, 2017 |
| Latest publication | May 10, 2022 |
Publications ranked by popularity score, then publication date.
US-11324738-B2 · May 10, 2022 · US
US-10961225-B2 · Mar 30, 2021 · US
US-2020325118-A1 · Oct 15, 2020 · US
US-10781205-B2 · Sep 22, 2020 · US
US-10689368-B2 · Jun 23, 2020 · US
US-2020129496-A1 · Apr 30, 2020 · US
US-10548884-B2 · Feb 4, 2020 · US
US-2019382381-A1 · Dec 19, 2019 · US
US-2019337925-A1 · Nov 7, 2019 · US
US-10435391-B2 · Oct 8, 2019 · US
Latest publications not already listed above.
US-10385039-B2 · Aug 20, 2019 · US
US-2019119271-A1 · Apr 25, 2019 · US
US-2019112294-A1 · Apr 18, 2019 · US
US-10196380-B2 · Feb 5, 2019 · US
US-2018179184-A1 · Jun 28, 2018 · US
US-2018134688-A1 · May 17, 2018 · US
US-9926297-B2 · Mar 27, 2018 · US
US-2017240530-A1 · Aug 24, 2017 · US
US-9670183-B2 · Jun 6, 2017 · US
US-2017015650-A1 · Jan 19, 2017 · US
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Heptares Therapeutics Ltd | 15 |
| Glaxosmithkline Ip Dev Ltd | 5 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07D401/14 | 18 |
| A61P29/00 | 17 |
| C07D417/14 | 17 |
| A61P25/28 | 15 |
| C07D413/14 | 15 |